NCT02921659View on ClinicalTrials.gov

Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Aging
Interventions
DIETARY_SUPPLEMENT

Niagen™

nicotinamide riboside chloride, 250mg capsules

DIETARY_SUPPLEMENT

Placebo

silicified microcrystalline cellulose, vegetarian capsule

Trial Locations (1)

80309

Clinical Translational Research Center, Boulder

All Listed Sponsors
collaborator

ChromaDex, Inc.

INDUSTRY

lead

University of Colorado, Boulder

OTHER

NCT02921659 - Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults | Biotech Hunter | Biotech Hunter